High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia

Journal of the American College of Cardiology

Volumn 71, Issue 19, 2018, Pages 2270-2271

  Stöhr, Robert ^a   Sandstede, Lukas ^a   Heine, Gunnar H ^a   Marx, Nikolaus ^a   Brandenburg, Vincent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; FERRIC ION; MALTOSE;

CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; HYPOPHOSPHATEMIA; IRON DEFICIENCY; IRON THERAPY; LETTER; PHOSPHATE BLOOD LEVEL; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; ANALOGS AND DERIVATIVES; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; HEART FAILURE; HEART STROKE VOLUME; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; PHYSIOLOGY;

ANEMIA, IRON-DEFICIENCY; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRIC COMPOUNDS; HEART FAILURE; HUMANS; HYPOPHOSPHATEMIA; INFUSIONS, INTRAVENOUS; MALTOSE; PILOT PROJECTS; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 85046782503     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.03.448     Document Type: Letter

References (5)

1. Anker, S.D., Comin Colet, J., Filippatos, G., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361 (2009), 2436–2448.
2. Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37 (2016), 2129–2200.
3. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol 70 (2017), 776–803.
4. Wolf, M., Koch, T.A., Bregman, D.B., Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28 (2013), 1793–1803.
5. Qin, Z., Liu, X., Song, M., et al. Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies. Atherosclerosis 261 (2017), 1–11.